ducibility and robustness of data, not necessarily involving misconduct but, e.g. poor quality study design or execution contributes to the failure of translation from experimental basic research into innovations in clinical diagnosis and treatment. [4] [5] [6] Is this a failure of peer review and editorial decision processes, as suggested by some [7] [8] [9] and if so, why and how to address the problem? The Editors of Cardiovascular Research have pledged to provide a quality review process. 10, 11 In the past years, we handled >6000 manuscripts and have gained experience and insight, often through examples where the process could have been better. As we are now in the last year of our mandate and a new team will take over in 2018, a reflection on the peer-review process is timely. This commentary also flows from the interest of young scientists in the review process, which was discussed in special sessions organized by the Scientists of Tomorrow at the FCVB meeting and the summer school of the ESC Council of Basic Cardiovascular Sciences [https://www.escardio.org/Councils/Councilon-Basic-Cardiovascular-Science-(CBCS) (29 September 2017, date last accessed)]. In the average time course of a scientific project, i.e. from idea to published manuscript, the publication process is a small fraction, estimated at less than 5% of the total duration. Nevertheless, it is the part that is often regarded as long and painful, as so well illustrated by the cartoon published more than 20 years ago and still valid.
Peer review as a tool in decision-making
Quality control for many processes involves review by experts in the matters at hand and is inherent to many aspects of research: scientific reports for publication, applications for research funding, prizes and awards, recruitment and promotions. Peer review in research is a form of quality assurance to the stakeholders in the process, such as institutions and funding bodies, and in the case of scientific reports, the community at large and the readers of the journal in particular.
In the publication process, as set out in the editorial policy of Cardiovascular Research, gathering reports from experts is essential to guide editorial decisions. Even though studies have shown that peer review is not infallible, 12 scientists performing research in the same field are still best placed to evaluate the appropriateness of the experimental approach, quality of the data, and novelty of the results and their contribution to progress in the field. 13 The input from reviewers is essential in identifying areas where gaps in the data need to be addressed to improve the quality and strengthen the conclusions. The editors' role in the decision process is the evaluation and weighing of the reviewers' report, taking into account the journal's mission and priorities and ensuring balance, consistency, and transparency in decisions. Quality peer review and editorial review are gatekeepers to the quality of publications but in a fast-changing publishing world, challenges arise and novel opportunities will change current practices profoundly. Can quality peer review be maintained with growing demand?
In the cardiovascular field, we recently collected and reviewed the publication output 14 with further growth to >58.000 publications in 2013, as illustrated here.
A generalist journal like PLOS ONE went from <5000 papers published in 2009 to >30 000 papers published in 2014; though this number has dropped, it was taken over by Scientific Reports [https://scholarlykitchen.sspnet.org/ 2016/08/23/scientific-reports-on-track-to-become-largest-journal-inthe-world (29 September 2017, date last accessed)]. As this growing number of published papers represents a fraction of the number of submitted manuscripts that went through review, one can rightfully ask the question how to manage and maintain the necessary quality.
In a simple calculation considering that for every paper there are three experts recruited to evaluate the work and that all authors of these manuscripts would contribute equally to the peer-review process, on average, each scientist would review three times the number of authored manuscripts. This is definitely not the case, as not all scientists participate in the process either by his or her own choice, or through editorial choices. Typically, the editors identify and place higher value on certain reviewers based on the quality of their reports. Reviewers are asked to rate a manuscript on criteria of scientific accuracy and novelty and how its content advances the field, but it is the comments and reflections that define the quality of a reviewer's report: any recommendation must be supported by a clear and careful analysis of the manuscript highlighting strengths and weaknesses against current practice and knowledge. (Un)fortunately, good reviewers are typically 'rewarded' by being invited more often than others.
Another limiting factor is a growing number of junior scientists who no longer necessarily follow an academic career, either by choice or forced by lack of funding. [15] [16] [17] The large number of PhD and temporary postdoctoral positions contributes to the growth in scientific output, but no longer guarantees a concomitantly expanding pool of more experienced reviewers. Not only is the pool of reviewers not keeping tread with the demand, there are threats to quality of peer review beyond the sheer number of submissions. Lack of rewards for participation in the process, 18 poor training and feedback from mentors and from editors due to time constraints, and reviewer fatigue for resubmissions are additional factors that are not conducive to quality.
A metrics-driven environment creates a waterfall approach to journals
Current incentives and rewards stimulate competition among those pursuing academic careers, contributing to the 'publication pressure' and the Not only is the number of manuscripts aspiring publication increasing but being published is no longer by itself sufficient in the current metricsdriven academic environment. In assessment of research output of institutions, research groups and individuals, quantitative measurements with variable weight are part of administrative and/or peer review, whether it is for funding, awards, or promotions. Metrics of journal publications include not only the number of papers but also a measure of their impact, derived from the journal metrics, usually impact factor or ranking, and citations. In this context, scientists are more and more taking a waterfall approach, selecting for first submission a journal ranking high in metrics, and after rejection, submitting to the 'next' journal and so on. This practice increases the burden on editors and reviewers, and can trigger reviewer (and editor) fatigue and irritation, that are damaging to the quality of the review process.
The threats from abuse of metrics in what should be an objective expert-based peer review also should not be underestimated. Guided by the (metrics-based) track record of authors, a manuscript may be viewed more or less favourably by reviewers and editors, an observation that has called for blinded review.
Reporting of scientific results without prior peer review-towards data sharing
Biomedical research has traditionally relied mostly on dissemination of findings through peer-reviewed journals. Different disciplines have different practices such as (more rapid) publications in conference proceedings rather than in journals, e.g. in the engineering sciences. Other disciplines such as physics put out the raw data for scrutiny before publication though eventually a multi-author paper will be released.
The sharing of raw data of research findings can become reality in the current digital era and has an enormous potential to enhance the use of the data and their contribution to knowledge via innovative discoveries.
In biomedical and life sciences, data repositories have been successfully created [https://www.nature.com/sdata/policies/repositories (29 September 2017, date last accessed)]. Other types of data may experience serious hurdles for lack of harmonization of data standards and access portals. Access to raw data of clinical trials is intensely debated. 21 For sharing data, platforms need to be supervised and managed. Curating of data will remain necessary and requires investment and commitment from scientists and funders. In the biomedical field, some organizations have taken that commitment, e.g. EMBL-EBI managing molecular databases 22 and the BBMRI-ERIC biobanks. 23 This is a topic beyond this editorial reflection but high up on the overall scientific policy agenda.
Opening new horizons for access to quality-controlled data and reports
Sharing of actual data is only part of the dissemination process. Placing the raw data in context is an essential part of advancing scientific knowledge and stimulation of further research. A manuscript therefore is more than just data reporting and sharing. In the manuscript review process, evaluation of the data interpretation and positioning, and of the outlook for further study and for innovation, are essential elements as they provide the added value of a manuscript, beyond the mere data.
Variations on the classic editor-supervised manuscript review process are growing as e.g. in eLife, where reviewer comments are used to generate a single opinion of the editor which is transferred to authors who respond only to the editor. 24 Post-publication discussion fora within a journal or community environment can further increase insight in publications and data and enhance dissemination. The role of fora such as PubPeer and social media is under debate. 26 Simple social media highlighting papers are not sufficient to enhance dissemination as shown in a survey by Circulation.
27
Examples of success may come from the clinical community where discussions on treatment are supervised by experts and help dissemination and fine-tuning of novel therapies.
28
A future's scenario
Public access to data generated by public funds is a societal commitment by policymakers and should benefit the quality of science and improve impact for society. 29 It is up to the scientific community to ensure that data are correct and trustworthy. Novel technologies and algorithms can make for exciting future scenarios:
• An organized information flow from accessible, original data to the eventual scientific report that provides careful analysis and positioning of the data • Implementing the proper rewards and incentives. This will require reflection by academia and universities, 18 scientific societies, funders, policymakers, and society.
• Reflection of journals, publishers, and all stakeholders, on their role and the editorial framework.
• A next generation of peer reviewers. With the future in mind, we have to increase participation of young scientists in the process and (r)evolution of quality peer review.
Scientific societies with representative membership are often owners of journals and are in a unique position to take leadership and contribute to this much-needed debate. Increasing the deluge of new open-access journals discussed above is not the answer. Essential to any future scenario remains the quality of data and reports, to which the ESC journal family and Cardiovascular Research are committed. Peer-review will remain a cornerstone, albeit in new models. Involving young scientists is stimulated in the newly launched EHJ Case Reports [https://academic.oup. com/ehjcr (29 September 2017, date last accessed)] and is at the heart of the new Cardiovascular Research Onlife. Further initiatives are underway, including training in quality peer review; the editors will keep the finger at the pulse of an exciting future in scientific reporting.
